Table 1.
Descriptive Statistics (n = 5790)
| Variable | |
|---|---|
| Age: mean (range) | 57.40 (21-94) |
| TNM Stage: | N (%) |
| 0 | 736 (12.7%) |
| I | 2625 (45.3%) |
| IIa | 1298 (22.4%) |
| IIb | 729 (12.6%) |
| IIIa | 239 (4.1%) |
| IIIb | 116 (2.0%) |
| IIIc | 47 (.8%) |
| Estrogen receptor positive | 4268 (73.7%) |
| Progesterone receptor positive | 3628 (62.7%) |
| Treatment: | N (%) |
| Surgery only | 420 (7.3%) |
| Surgery/radiation | 2764 (47.7%) |
| Surgery/chemotherapy | 640 (11.1%) |
| Surgery/radiation/chemotherapy | 1966 (34.0%) |
| Anthracycline regimen | 1973 (75.7%) |
| Non-anthracycline regimen | 646 (24.3%) |
| Tamoxifen | 3554 (61.4%) |
| Follow up years: mean (range) | 7.02 (.20, 18.15) |
| Vital Status: | N (%) |
| Alive, NED* | 4741 (81.9%) |
| Alive with this cancer | 123 (2.1%) |
| Alive with other cancer | 62 (1.1%) |
| Expired, NED | 354 (6.1%) |
| Expired with this cancer | 388 (6.7%) |
| Expired with other cancer | 121 (2.1%) |
| Expired, treatment complications | 1 (.0%) |
*NED: no evidence of disease